Literature DB >> 24608255

Comparison of meibomian gland loss and expressed meibum grade between the upper and lower eyelids in patients with obstructive meibomian gland dysfunction.

Youngsub Eom1, Kwang-Eon Choi, Su-Yeon Kang, Hyung Keun Lee, Hyo Myung Kim, Jong Suk Song.   

Abstract

PURPOSE: The aim of this study was to compare meibomian gland loss (MGL) and expressed meibum grade between upper and lower eyelids in patients with obstructive meibomian gland dysfunction (MGD) and to evaluate the correlation between these 2 parameters and other clinical measurements.
METHODS: Twenty-six eyes of 26 patients with obstructive MGD were enrolled. Upper and lower MGLs were evaluated using noncontact meibography. Expressed meibum quality was assessed in 8 glands of the central third area of the upper and lower eyelids on a scale of 0 to 3 for each gland (total score range, 0-24). Tear film stability was evaluated based on tear break-up time (TBUT), and corneal staining was graded according to the National Eye Institute scale (range, 0-15).
RESULTS: The mean MGL in the lower eyelids (24.1% ± 10.8%) was significantly greater than that of the upper eyelids (11.2% ± 5.2%) (P < 0.001). The mean expressed meibum grade in the lower eyelids (16.5 ± 5.1) was also significantly larger than that of the upper eyelids (11.2 ± 5.2) (P < 0.001). MGL was significantly correlated with expressed meibum grade in both eyelids (r = 0.451, P = 0.021 in the upper eyelids; r = 0.626, P = 0.001 in the lower eyelids). The meibum grades of both the upper and lower eyelids were negatively correlated with TBUT and positively correlated with corneal staining score. However, the MGL in both the eyelids was not correlated with TBUT or with corneal staining score.
CONCLUSIONS: In patients with obstructive MGD, MGL and meibum grade in the lower eyelids were significantly greater than those of the upper eyelids. Although MGL and meibum quality showed a positive correlation with each other, TBUT and corneal staining score were significantly correlated with only meibum grade, and not with MGL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24608255     DOI: 10.1097/ICO.0000000000000092

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  18 in total

1.  Clinical features and treatment outcomes of patients with tearing after chemotherapy.

Authors:  Jinhwan Park; Joohyun Kim; Sehyun Baek
Journal:  Eye (Lond)       Date:  2018-12-10       Impact factor: 3.775

2.  Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management (DREAM) study.

Authors:  Ebenezer Daniel; Maureen G Maguire; Maxwell Pistilli; Vatinee Y Bunya; Giacomina M Massaro-Giordano; Eli Smith; Pooja A Kadakia; Penny A Asbell
Journal:  Ocul Surf       Date:  2019-04-22       Impact factor: 5.033

3.  In vivo confocal microscopy classification in the diagnosis of meibomian gland dysfunction.

Authors:  Matthieu Randon; Vittoria Aragno; Rachid Abbas; Hong Liang; Antoine Labbé; Christophe Baudouin
Journal:  Eye (Lond)       Date:  2018-12-12       Impact factor: 3.775

4.  Intense pulsed light treatment of the upper and lower eyelids in patients with moderate-to-severe meibomian gland dysfunction.

Authors:  Ho Seok Chung; Ye Eun Han; Hun Lee; Jae Yong Kim; Hungwon Tchah
Journal:  Int Ophthalmol       Date:  2022-07-06       Impact factor: 2.031

5.  Quantitative measurement of optical properties and Hb concentration in a rodent model of inflammatory Meibomian gland dysfunction using spatial frequency domain imaging.

Authors:  Hyeongbeom Kim; Kyong Jin Cho; Anthony J Durkin; Bruce J Tromberg; Ilyong Park
Journal:  Biomed Opt Express       Date:  2022-02-04       Impact factor: 3.732

6.  Automatic identification of meibomian gland dysfunction with meibography images using deep learning.

Authors:  Yi Yu; Yiwen Zhou; Hongmei Zheng; Yanning Yang; Miao Tian; Yabiao Zhou; Yuejiao Tan; Lianlian Wu
Journal:  Int Ophthalmol       Date:  2022-09-19       Impact factor: 2.029

7.  Relationship between meibomian gland loss in infrared meibography and meibum quality in dry eye patients.

Authors:  Minji Ha; Si-Eun Oh; Woong-Joo Whang; Kyung-Sun Na; Eun Chul Kim; Hyun-Seung Kim; Jin Soo Kim; Ho Sik Hwang
Journal:  BMC Ophthalmol       Date:  2022-07-04       Impact factor: 2.086

8.  A multicenter cross-sectional survey of dry eye clinical characteristics and practice patterns in Korea: the DECS-K study.

Authors:  Youngsub Eom; Joon Young Hyon; Hyung Keun Lee; Jong Suk Song; Hyo Myung Kim
Journal:  Jpn J Ophthalmol       Date:  2021-01-19       Impact factor: 2.447

Review 9.  Meibomian gland dysfunction: hyperkeratinization or atrophy?

Authors:  James V Jester; Geraint J Parfitt; Donald J Brown
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

10.  Clinical efficacy of eyelid hygiene in blepharitis and meibomian gland dysfunction after cataract surgery: a randomized controlled pilot trial.

Authors:  Youngsub Eom; Kyung Sun Na; Ho Sik Hwang; Kyong Jin Cho; Tae-Young Chung; Roo Min Jun; Byung Yi Ko; Yeoun Sook Chun; Hyun Seung Kim; Jong Suk Song
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.